Insider Trading activities at Xynomic Pharmaceuticals Holdings, Inc. (BCACU)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xynomic Pharmaceuticals Holdings, Inc. (BCACU) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xynomic Pharmaceuticals Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1697805.

Total stock buying since 2017: $0.
Total stock sales since 2017: $0.
Total stock option exercises since 2017: $0.


3 insiders reported insider trading activities at Xynomic Pharmaceuticals Holdings, Inc. (BCACU):
Insider trading activities of Xu Peixin
Insider trading activities of Bison Capital Holding Co Ltd
Insider trading activities of Jiang Fengyun

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Xynomic Pharmaceuticals Holdings, Inc. (BCACU).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2019 217,960 $0 0 $0 0 $0
2017 118,125 $0 0 $0 0 $0

Table 2. Monthly summary of insider trading at Xynomic Pharmaceuticals Holdings, Inc. (BCACU).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-05 217,960 $0 0 $0 0 $0
2017-06 118,125 $0 0 $0 0 $0

Table 3. Detailed insider trading at Xynomic Pharmaceuticals Holdings, Inc. (BCACU)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-05-15 Xu Peixin Buy 108,980 .00 0
2019-05-15 Bison Capital Holding Co Ltd Buy 108,980 .00 0
2017-06-28 Jiang Fengyun Buy 39,375 .00 0
2017-06-28 Xu Peixin (President) Buy 39,375 .00 0
2017-06-28 Bison Capital Holding Co Ltd Buy 39,375 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises of BCACU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xynomic Pharmaceuticals Holdings, Inc. (symbol BCACU, CIK number 1697805) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.